CONTACT
+91 80 2808 2808
info@biocon.com

Press Releases 2016

Biocon  /  News – Posts  /  Press Releases  /  Press Releases 2016

Journal of the American Medical Association (JAMA) Publishes Mylan and Biocon’s Proposed Biosimilar Trastuzumab Phase 3 Data

  • Posted by: BIOCON

Biocon Features in Asia IP Elite 2016 List

  • Posted by: BIOCON

Biocon’s Novel Diabetes Education Initiative for Medical Practitioners ‘ABIDE’ Awarded by RSSDI

  • Posted by: BIOCON

Biocon Collaborates with Healthcare Professionals for a Public Awareness Campaign on Diabetes Prevention & Management Across India

  • Posted by: BIOCON

Mylan and Biocon Announce U.S. FDA Submission for Proposed Biosimilar Trastuzumab

  • Posted by: BIOCON

Mylan and Biocon Announce Regulatory Submission for Insulin Glargine Accepted for Review by European Medicines Agency

  • Posted by: BIOCON

Biocon Ranked Among Global Top Ten Biotech Employers; The only Asian Company to Feature in 2016 Rankings Biocon moves up to No. 9 from No. 13 last year

  • Posted by: BIOCON

Biocon Q2 FY17 Revenue Up 21%; EBITDA Up 45%; Revenues at Rs 992 Crs.; EBITDA at Rs 277 Crs.; Net Profit at Rs 147 Crs.

  • Posted by: BIOCON

Biocon Appoints Suresh Subramanian as Head of Branded Formulations (India) Business

  • Posted by: BIOCON

Kiran Mazumdar Shaw Appointed ‘Knight of the Legion of Honour’ by the Government of France

  • Posted by: BIOCON
  • 1
  • 2
Share
Previous Next
Close
Test Caption
Test Description goes like this